Avellino Labs is a global leader in gene therapy and molecular diagnostics, and the pioneer in personalized medicine for eye care. Avellino Labs is pioneering CRISPR gene editing to manage and potentially cure inherited diseases. Avellino Labs continues to expand its diagnostics capabilities, buildi... Read more
View all
Akoya Biosciences
Series D • San Francisco, United States
BioMarin Pharmaceutical
Post IPO Debt • San Rafael, United States
Exicure
Post IPO Equity • Skokie, United States
BioAge
Series C • Richmond, United States
Enko
Series C • Stonington, United States
Verve Therapeutics
Series B • Cambridge, United States
Biogen
Cambridge, United States
Leapcure
Seed • Los Angeles, United States
Mission Bio
Series C • San Francisco, United States
Genentech
Venture • South San Francisco, United States
Vir Biotechnology
Post IPO Equity • San Francisco, United States
KBI Biopharma
Venture • Durham, United States